Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria
DOI: 10.1200/jco.2021.39.15_suppl.4008
文献链接: https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.4008
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Shaohua Li; Chong Zhong; Qiang Li; Jingwen Zou; Qiaoxuan Wang; Changzhen Shang; Yuan Cheng; Mingrong Cao; Huakun Huang; Jie Mei; Lianghe Lu; Rongce Zhao; Wenping Lin; Yuhua Wen; Zhixing Guo; Yihong Ling; Lie Zheng; Wei Wei; Rongping Guo

